PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Stroke 146,992 3 0.00 -0.90 0.19 0.59
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Renal Failure 73,993 1 0.00 -0.97 0.06 0.58
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Acute Coronary Syndromes 9,133 2 0.01 -0.94 0.12 0.65
Arixtra (Fondaparinux Sodium)- FDA 16 Drug Disease Pain 409,851 1 0.00 -0.97 0.06 0.55
Neuropathy Diabetic 15 Disease Disease Arrhythmia 29,330 1 0.00 -0.97 0.07 0.60
Neuropathy Diabetic 15 Disease Disease Hyperglycemia 28,168 2 0.00 -0.93 0.13 0.62
Neuropathy Diabetic 15 Disease Disease Diabetic Retinopathy 14,494 1 0.00 -0.97 0.07 0.62
Neuropathy Diabetic 15 Disease Disease Pain 409,851 3 0.00 -0.89 0.20 0.57
Neuropathy Diabetic 15 Disease Disease Muscle Weakness 9,178 2 0.01 -0.93 0.13 0.65
Neuropathy Diabetic 15 Disease Disease Hyperlipidemia 15,317 1 0.00 -0.97 0.07 0.62
Neuropathy Diabetic 15 Disease Disease Inflammation 252,734 1 0.00 -0.97 0.07 0.56
Complement Component C3c 15 Target Disease Carcinoma 433,099 1 0.00 -0.97 0.07 0.55
Complement Component C3c 15 Target Disease Depression 220,092 1 0.00 -0.97 0.07 0.56
Complement Component C3c 15 Target Disease Cancer 1,053,491 1 0.00 -0.97 0.07 0.53
Complement Component C3c 15 Target Disease Infection 766,637 1 0.00 -0.97 0.07 0.54
Complement Component C3c 15 Target Disease Hepatitis B 57,815 2 0.00 -0.93 0.13 0.60
Complement Component C3c 15 Target Disease Viral Disease 2,087 1 0.01 -0.97 0.07 0.67
Complement Component C3c 15 Target Disease Hepatitis 163,842 2 0.00 -0.93 0.13 0.58
Complement Component C3c 15 Target Disease Lung Cancer 91,416 1 0.00 -0.97 0.07 0.58
Glutathione Transferase Omega-1 14 Target Disease Hypoglycemia 20,698 1 0.00 -0.96 0.07 0.61
Glutathione Transferase Omega-1 14 Target Disease Cancer 1,053,491 6 0.00 -0.76 0.43 0.57
Glutathione Transferase Omega-1 14 Target Disease Ovarian Cancer 33,996 1 0.00 -0.96 0.07 0.60
Glutathione Transferase Omega-1 14 Target Disease Hyperglycemia 28,168 1 0.00 -0.96 0.07 0.61
Glutathione Transferase Omega-1 14 Target Disease Diabetic Retinopathy 14,494 1 0.00 -0.96 0.07 0.62
Glutathione Transferase Omega-1 14 Target Disease Breast Cancer 173,695 3 0.00 -0.89 0.21 0.59
Glutathione Transferase Omega-1 14 Target Disease Inflammation 252,734 1 0.00 -0.96 0.07 0.56
Arava (Leflunomide)- FDA 14 Drug Disease Tuberculosis 146,217 1 0.00 -0.96 0.07 0.57
Arava (Leflunomide)- FDA 14 Drug Disease Inflammatory Bowel Disease 24,375 1 0.00 -0.96 0.07 0.61
Arava (Leflunomide)- FDA 14 Drug Disease Infection 766,637 1 0.00 -0.96 0.07 0.54
Arava (Leflunomide)- FDA 14 Drug Disease Hepatitis B 57,815 1 0.00 -0.96 0.07 0.59
Arava (Leflunomide)- FDA 14 Drug Disease Influenza 67,933 1 0.00 -0.96 0.07 0.59
Arava (Leflunomide)- FDA 14 Drug Disease Arthritis 128,324 10 0.01 -0.53 0.71 0.63
Arava (Leflunomide)- FDA 14 Drug Disease Anemia 81,663 1 0.00 -0.96 0.07 0.58
Arava (Leflunomide)- FDA 14 Drug Disease Joint Pain 4,215 1 0.00 -0.96 0.07 0.65
Arava (Leflunomide)- FDA 14 Drug Disease Rheumatoid Arthritis 78,952 9 0.01 -0.60 0.64 0.63
Arava (Leflunomide)- FDA 14 Drug Disease Hepatitis 163,842 1 0.00 -0.96 0.07 0.57
Arava (Leflunomide)- FDA 14 Drug Disease Psoriasis 26,882 2 0.00 -0.93 0.14 0.62
Arava (Leflunomide)- FDA 14 Drug Disease Pain 409,851 2 0.00 -0.93 0.14 0.56
Arava (Leflunomide)- FDA 14 Drug Disease Ankylosing Spondylitis 9,665 1 0.00 -0.96 0.07 0.63
Arava (Leflunomide)- FDA 14 Drug Disease Inflammation 252,734 2 0.00 -0.93 0.14 0.57
Dronedarone Hydrochloride 14 Drug Disease Lung Cancer 91,416 1 0.00 -0.96 0.07 0.58
Dronedarone Hydrochloride 14 Drug Disease Cancer 1,053,491 1 0.00 -0.96 0.07 0.53
Dronedarone Hydrochloride 14 Drug Disease Influenza 67,933 2 0.00 -0.93 0.14 0.60
Dronedarone Hydrochloride 14 Drug Disease Hepatitis 163,842 1 0.00 -0.96 0.07 0.57
Dronedarone Hydrochloride 14 Drug Disease Lung Cancer 91,416 1 0.00 -0.96 0.07 0.58
Aredia (Pamidronate Disodium)- FDA 14 Drug Disease Pain 409,851 4 0.00 -0.85 0.29 0.58
Aredia (Pamidronate Disodium)- FDA 14 Drug Disease Breast Cancer 173,695 2 0.00 -0.93 0.14 0.58
Aflibercept (Eylea)- FDA 14 Drug Disease Diabetic Retinopathy 14,494 1 0.00 -0.96 0.07 0.62
Aflibercept (Eylea)- FDA 14 Drug Disease Breast Cancer 173,695 1 0.00 -0.96 0.07 0.57
Aflibercept (Eylea)- FDA 14 Drug Disease Lung Cancer 91,416 1 0.00 -0.96 0.07 0.58